UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 13, 2019
CELEXUS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 000-52069 | 98-0466350 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification Number) |
8275 S. Eastern Ave. Suite 200 Las Vegas, NV | 88123 |
| (Address of principal executive offices) | (Zip Code) |
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
On May 13, 2019, Celexus, Inc. (the “Company”) filed a current report on Form 8-K which contained an incorrect statement regarding the current status of the Company’s acquisition of HempWave, f/k/a Bio Distribution. The Company has entered into a definitive agreement by which it will acquire HempWave subject to completion of an appraisal satisfactory to management of both companies.
Item 5.02 Appointment of Certain Officers
HempWave, a company to be acquired as a subsidiary by Celexus pursuant to certain acquisition terms, has appointed David Soto as its Chief Executive Officer.
An accomplished venture capitalist and startup leader with successful exits from thriving enterprises, Soto positions HempWave as the principal figure in the growing hemp industry.
Since 2006, Soto has been a partner with Asturia Ventures, where his strategic planning has ensured the future growth of target markets and helped clients with raising capital, mergers and acquisitions, as well as transitions and exit strategies.
Previously, he was a senior partner with Benchmark Company, an investment advisory firm that developed investment management software to better manage and grow its clients’ portfolios.
Item 9.01 Financial Statements and Exhibits
None.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 20, 2019
Celexus, Inc.
/s/ Lisa Averbuch
Lisa Averbuch, President
